Cargando…
Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due to sparse evidence-based guidance. This multicentre retrospective study investigated the safety of systemic therapy with causality assessment in a real-world cohort of older adults (≥ 65 years) with psoriasi...
Autores principales: | TER HAAR, Elke L. M., TEN BRUIN, Eline E., BRONKHORST, Ewald M., BORGONJEN, Rinke J., KLEINPENNING, Marloes M., KOP, Else N., VISCH, M. Birgitte, VAN DE KERKHOF, Peter C. M., DE JONG, Elke M. G. J., LUBEEK, Satish F. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677276/ https://www.ncbi.nlm.nih.gov/pubmed/36065742 http://dx.doi.org/10.2340/actadv.v102.2412 |
Ejemplares similares
-
Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups
por: VAN WINDEN, Marieke E. C., et al.
Publicado: (2020) -
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
por: VAN MUIJEN, Marloes. E., et al.
Publicado: (2022) -
Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups
por: van Winden, M.E.C., et al.
Publicado: (2020) -
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
por: ter Haar, E. L. M., et al.
Publicado: (2022) -
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
por: TER HAAR, Elke L. M., et al.
Publicado: (2023)